Clinical Trials List
2021-10-01 - 2027-06-30
Phase III
Recruiting13
Terminated3
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Pin Li Digestive System Department
- Yun-Cheng Hsieh Digestive System Department
- Yi-Ping Hung Division of Hematology & Oncology
- Shao-Jung Hsu Digestive System Department
- Rheun-Chuan Lee Division of Hematology & Oncology
- Chien-An Liu Division of Radiology
- Yee Chao Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Ching Chen Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉奕廷 Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- Chien-Jui Huang Division of Hematology & Oncology
- 蘇勇曄 Division of Hematology & Oncology
- Yan-Shen Shan Division of Hematology & Oncology
- Kwang-Yu Chang Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- 顏志傑 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mao-Chih Hsieh Division of General Surgery
- 余信賢 Division of General Surgery
- Tzu-Yao Liao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wei-Hong Cheng Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- Tsu-Yi Chao 無
- 莊博雅 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YU-HSUAN SHIH 無
- HSIN-CHEN LIN Division of Hematology & Oncology
- Tsung -Chih Chen 無
- Chieh-Lin Teng 無
- CHENG-HSIEN LIN 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kuan-Der Lee 無
- Cheng-I Hsieh Division of Hematology & Oncology
- Huey-En Tzeng 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Jeng-Shiun Du Division of Hematology & Oncology
- Li-Tzong Chen Digestive System Department
- Wang Yao-Kuang Digestive System Department
- 高育青 無
- Tsung-Jang Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Tsai-Sheng Yang 無
- Ming-Mo Hou 無
- 余紹銘 無
- Wen-Chi Chou Division of Hematology & Oncology
- 黃文冠 無
- Hung-Chih Hsu 無
- 吳教恩 無
- Wen-Chi Shen 無
- Po-Jung Su 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
100 participants
-
Global
600 participants
